Cytomegalovirus (CMV) Serum

About Cytomegalovirus (CMV) Serum

Cytomegalovirus Serum for Viral Immunology and Infectious Disease Research

Our Cytomegalovirus (CMV) Serum is sourced from IRB-consented donors with clinically documented cytomegalovirus infection or CMV seropositivity. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality. Cytomegalovirus is a ubiquitous human betaherpesvirus that establishes lifelong latency after primary infection, with periodic reactivation controlled by the host immune response. This serum supports viral serology, infectious disease immunology and diagnostic assay development.

Host Immune Response to CMV Infection and Why Serum

• Primary CMV infection elicits a virus-specific antibody response; IgM typically marks recent or reactivated infection while IgG persists indefinitely and defines serostatus. Both are serum analytes, which makes serum the standard matrix for CMV serological work.
• IgG avidity maturation over time after primary infection is used to help distinguish recent from remote infection, and avidity assays are performed on serum.
• After primary infection CMV persists latently, and control of reactivation depends on cellular immunity — a major reason CMV serostatus is a critical variable in transplantation and immunosuppression research.
• CMV drives a strong and durable adaptive immune response and is widely used as a model antigen system in human immunology, including immunosenescence and inflammaging research.
• Serum from characterised seropositive and seronegative donors provides the reference material needed to develop, calibrate and validate CMV immunoassays and multiplex serology panels.
• Serum is acellular; it is suited to antibody quantification, cytokine and inflammatory mediator immunoassays and proteomic profiling rather than to cell-based assays.

Donor Stratification Available

• CMV serostatus: IgG-positive, IgM-positive, or seronegative donors
• Primary infection versus established latent or past infection where documented
• Symptomatic versus asymptomatic infection at the time of collection
• Immunocompetent donors versus donors with documented immunosuppression
• Antiviral treatment status where documented
• Matched healthy controls available

Product Features

• Collected from donors with clinically confirmed cytomegalovirus infection or documented serostatus
• Processed and frozen within 24 hours of collection
• Research Use Only (RUO)
• IRB-approved protocols with documented consent
• Custom aliquot volumes available upon request

De-identified Donor Data

• Diagnosis confirmation and CMV serostatus where available
• Age, sex assigned at birth, and ethnicity
• Donor-reported medical history and comorbidities
• Concurrent medications, including antiviral or immunosuppressive therapy where reported

Applications

• CMV-specific IgG and IgM immunoassay development and validation
• IgG avidity assay development for recent versus remote infection
• Serostatus reference and calibrator panels for diagnostic manufacturers
• Antibody titre and neutralisation serology research
• Serum cytokine and inflammatory mediator profiling in viral infection
• Vaccine and antiviral candidate immunogenicity research
• Transplant and immunosuppression risk-stratification biomarker studies
• Multiplex infectious disease serology panel development

Other Cytomegalovirus Specimen Types

• Cytomegalovirus Plasma
• Cytomegalovirus Whole Blood
• Cytomegalovirus PBMC

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering & Customization

Cytomegalovirus serum is available in standard and custom volumes. For pricing, current availability, international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To browse donor cohorts across our full inventory, visit our human serum page.